A novel aspartate aminotransferase inhibitor named gostatin was isolated as crystals from the culture filtrate of Streptomyces sumanensis . The structure has been established to be 5-amino-2-carboxy-4-oxo-l ,4,5,6-tetrahydropyridine-3-acetic acid by X-ray crystallographic analysis (K. Ibata et al., manuscript in preparation). The results of chemical and instrumental analyses of the inhibitor are described in this paper.Gostatin showed time-dependent inhibitory action against aspartate aminotransferases and alanine aminotransferase. Both pyridoxal phosphate-and pyridoxamine phosphate-linked enzymes were sensitive to the inhibitor.
1961A novel cyclic amino acid named gostatin, produced by Streptomy'ces sumanensis NK-23, shows a strong inhibitory activity against aspartate aminotransferases (Be 2.6.1.1, GOT)* of various origins.! ,2) This inhibitor was isolated as crystals and the structure was determined to be 5-amino-2-carboxy-4-oxo-l ,4,5,6-tetrahydropyridine-3-acetic acid ( Fig. 1) by Xray crystallographic analysis (K. Ibata et al., manuscript in preparation).In this paper, the isolation and some chemical and biochemical properties of gostatin are reported.
MATERIALS AND METHODSMicroorganism and culture conditions. Streptomyces sumanensis NK-23, which was isolated from soil by the authors,1,2) was used in this experiment. The strain was cultured under the optimum conditions for the production of gostatin in a Marubishi MSJ-U2 jar fermentor. 2 ) The culture filtrate at 114 hr cultivation was used for the preparation of the inhibitor.Assay ofgostatin activity. Gostatin activity was assayed by the method described in the previous paper. 2 ) Isolation ofgostatin. The isolation procedure reported in the previous paper was modified. 1 ) The culture filtrate (35 liters) was adjusted to pH 4.0 with formic acid, and activated charcoal (2%, w/v) was added. After the mixture stood for 30 min, the non~adsorbingfraction was collected by filtration .. This solution was applied onto a column (10x35cm) of Dowex lx4 (formate type, 100",200 mesh) previously equilibrated with 50 mM ammonium formate-formic acid buffer (pH 4.0). Gostatin was weakly adsorbed to the column and eluted with 50 mM ammonium formate-formic acid buffer (pH 4.0). Active fractions thus obtained (36 liters) were then applied onto a column (10 x 35cm) of Dowex 1 x4 (OH type, 100",200 mesh) and eluted with 0.5 M NH 4 CI solution. The fractions containing gostatin were pooled (14 liters), evaporated in vacuo to dryness and dissolved in a minimum volume of water (1150 ml). After the solution was adjusted to pH 4.0 with 6N HCI, methanol was added at a final concentration of 50% (v/v) and the precipitate was removed by filtration. Gostatin was precipitated from the supernatant by adding ethanol at a final concentration of 60% and allowing the mixture to stand overnight. The precipitates were collected by centrifugation (10,000 x g, 10 min) and dissolved in 170 ml of water. Gostatin was crystallized from this solution by adjusting the pH (pH 4.0) and adding methanol...